Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · MAQ

Kit, Dna Detection, Human Papillomavirus

FDA classification: Unknown. Device class 3.

Product / regulatory recordCompanyPathwayDecision dateSource
cobas HPVP100020/S066
Roche Molecular Systems, Inc.PMA supplementOct 27, 2026FDA
cobas HPVP190028/S026
Roche Molecular Systems, Inc.PMA supplementOct 27, 2026FDA
Alinity m HR HPVP230003/S019
Abbott Molecular, Inc.PMA supplementSep 2, 2026FDA
Becton Dickinson and CompanyPMA supplementAug 19, 2026FDA
Becton Dickinson and CompanyPMA supplementAug 14, 2026FDA
Alinity m HR HPVP230003/S015
Abbott Molecular, Inc.PMA supplementJul 23, 2026FDA
Alinity m HR HPVP230003/S018
Abbott Molecular, Inc.PMA supplementJun 22, 2026FDA
cobas HPVP190028/S023
Roche Molecular Systems, Inc.PMA supplementJun 16, 2026FDA
Abbott Molecular, Inc.PMA supplementJun 8, 2026FDA
Alinity m HR HPVP230003/S017
Abbott Molecular, Inc.PMA supplementMay 28, 2026FDA
Alinity m HR HPVP230003/S016
Abbott Molecular, Inc.PMA supplementMay 19, 2026FDA
Alinity m HR HPVP230003/S013
Abbott Molecular, Inc.PMA supplementMay 15, 2026FDA
cobas HPVP190028/S024
Roche Molecular Systems, Inc.PMA supplementApr 23, 2026FDA
Becton Dickinson and CompanyPMA supplementApr 2, 2026FDA
Becton Dickinson and CompanyPMA supplementApr 2, 2026FDA
cobas HPVP100020/S065
Roche Molecular Systems, Inc.PMA supplementMar 17, 2026FDA
cobas HPVP190028/S025
Roche Molecular Systems, Inc.PMA supplementMar 17, 2026FDA
Alinity m HR HPVP230003/S011
Abbott Molecular, Inc.PMA supplementMar 12, 2026FDA
Alinity m HR HPVP230003/S012
Abbott Molecular, Inc.PMA supplementFeb 24, 2026FDA
Becton Dickinson and CompanyPMA supplementFeb 12, 2026FDA
Alinity m HR HPVP230003/S010
Abbott Molecular, Inc.PMA supplementJan 6, 2026FDA
cobas HPVP100020/S064
Roche Molecular Systems, Inc.PMA supplementDec 31, 2025FDA
cobas HPVP190028/S022
Roche Molecular Systems, Inc.PMA supplementDec 31, 2025FDA
COBAS HPV TESTP100020/S063
Roche Molecular Systems, Inc.PMA supplementDec 15, 2025FDA
Alinity m HR HPVP230003/S009
Abbott Molecular, Inc.PMA supplementOct 17, 2025FDA
Alinity m HR HPVP230003/S008
Abbott Molecular, Inc.PMA supplementSep 24, 2025FDA
cobas HPVP190028/S021
Roche Molecular Systems, Inc.PMA supplementSep 19, 2025FDA
Alinity m HR HPVP230003/S006
Abbott Molecular, Inc.PMA supplementSep 10, 2025FDA
Becton Dickinson and CompanyPMA supplementAug 25, 2025FDA
cobas HPVP190028/S020
Roche Molecular Systems, Inc.PMA supplementAug 7, 2025FDA
Abbott Molecular, Inc.PMA approvalNov 1, 2023FDA
Roche Molecular Systems, Inc.PMA approvalApr 3, 2020FDA
Roche Molecular Systems, Inc.PMA approvalApr 19, 2011FDA
Source information

Follow the FDA links to view the original records.

All device categories